Summary: The natural history and immunobiology of chlamydia trachomatis genital infection and implications for chlamydia control

Journal of Infectious Diseases

Volumn 201, Issue SUPPL. 2, 2010, Pages

  Gottlieb, Sami L ^a   Martin, David H ^b   Xu, Fujie ^a   Byrne, Gerald I ^c   Brunham, Robert C ^d  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^c UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^d BRITISH COLUMBIA CENTRE FOR DISEASE CONTROL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; DISEASE MARKER; GENITAL TRACT INFECTION; HEALTH PROGRAM; HUMAN; IMMUNE RESPONSE; IMMUNOBIOLOGY; INFECTION RISK; MEDICAL LITERATURE; MEDICAL RESEARCH; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REINFECTION; REVIEW; SCREENING TEST; ARTICLE; FEMALE; HEALTH SURVEY; IMMUNOLOGY; INNATE IMMUNITY; PATHOLOGY; PHYSIOLOGY; RECURRENT DISEASE; RESEARCH; RISK FACTOR;

BIOLOGICAL MARKER;

BIOLOGICAL MARKERS; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; FEMALE; HUMANS; IMMUNITY, INNATE; POPULATION SURVEILLANCE; RECURRENCE; RESEARCH; RISK FACTORS;

EID: 77953108527     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/652401     Document Type: Review

References (121)

1. Centers for Disease Control and Prevention. Sexually Transmitted Disease Surveillance 2007 Supplement, Chlamydia Prevalence Monitoring Project Annual Report 2007. Atlanta: US Department of Health and Human Services, Centers for Disease Control and Prevention, 2009.
2. Weinstock H, Berman S, Cates W Jr. Sexually transmitted diseases among American youth: incidence and prevalence estimates, 2000. Perspect Sex Reprod Health 2004; 36(1): 6-10.
3. World Health Organization. Global prevalence and incidence of selected curable sexually transmitted infections: overview and estimates 2001. http://www.who.int/hiv/pub/sti/who-hiv-aids-2001.02.pdf. Accessed 4 February 2010.
4. Stamm WE. Chlamydia trachomatis infections in the adult. In: Holmes KK, Sparling PF, Stamm WE, et al, eds. Sexually transmitted diseases. New York: McGraw Hill Medical, 2008: 575-594.
5. Centers for Disease Control and Prevention. Infertility prevention program, USA. http://www.cdc.gov/std/infertility/ipp.htm. Accessed 4 February 2010.
6. Low N; SCREen project team. Publication of report on chlamydia control activities in Europe. Euro Surveill 2008; 13(28).pii:: 8924; erratum: Euro Surveill 2008; 13(34).pii: 18960.
7. Gottlieb SL, Brunham R, Byrne GI, Martin DH, Xu F, Berman SM. Introduction: the natural history and immunobiology of Chlamydia trachomatic genital infection and implications for chlamydia control. J Infect Dis 2010; 201(Suppl 2): S85-S87 (in this supplement).
8. Batteiger B, Xu F, Johnson RE, Rekart ML. Protective immunity to Chlamydia trachomatis genital infection: evidence from human studies. J Infect Dis 2010; 201 (Suppl 2): S178-S189 (in this supplement).
9. Byrne GI. Chlamydia trachomatis strains and virulence: rethinking links to infection prevalence and disease severity. J Infect Dis 2010; 201(Suppl 2): S126-S133 (in this supplement).
10. Darville T, Hiltke T. Pathogenesis of genital tract disease due to Chlamydia trachomatis. J Infect Dis 2010; 201 (Suppl 2): S114-S125 (in this supplement).
11. Geisler WM. Duration of untreated, uncomplicated Chlamydia trachomatis genital infection and factors associated with chlamydia resolution: a review of human studies. J Infect Dis 2010; 201(Suppl 2): S104-S113 (in this supplement).
12. Gottlieb SL, Berman SM, Low N. Screening and treatment to prevent sequelae in women with Chlamydia trachomatis genital infection: how much do we know? J Infect Dis 2010; 201 (Suppl 2): S156-S167 (in this supplement).
13. Haggerty CL, Gottlieb SL, Taylor BD, Low N, Xu F, Ness RB. Risk of sequelae after Chlamydia trachomatis genital infection in women. J Infect Dis 2010; 201(Suppl 2): S134-S155 (in this supplement).
14. Miyairi I, Ramsey KH, Patton DL. Duration of untreated chlamydial genital infection and factors associated with clearance: review of animal studies. J Infect Dis 2010; 201 (Suppl 2): S96-S103 (in this supplement).
15. Rank RG, Whittum-Hudson JA. Protective immunity to chlamydial genital infection: evidence from animal studies. J Infect Dis 2010; 201(Suppl 2): S168-S177 (in this supplement).
16. Wyrick PB. Chlamydia trachomatis persistence in vitro: an overview. J Infect Dis 2010; 201(Suppl 2): S88-S95 (in this supplement).
17. Stephens RS. The cellular paradigm of chlamydial pathogenesis. Trends Microbiol 2003; 11(1): 44-51.
18. Rasmussen SJ, Eckmann L, Quayle AJ, et al. Secretion of proinflammatory cytokines by epithelial cells in response to Chlamydia infection suggests a central role for epithelial cells in chlamydial pathogenesis. J Clin Invest 1997; 99(1): 77-87.
19. Brunham RC, Peeling RW. Chlamydia trachomatis antigens: role in immunity and pathogenesis. Infect Agents Dis 1994; 3(5): 218-233.
20. Darville T, O'Neill JM, Andrews CW Jr, Nagarajan UM, Stahl L, Ojcius DM. Toll-like receptor-2, but not Toll-like receptor-4, is essential for development of oviduct pathology in chlamydial genital tract infection. J Immunol 2003; 171(11): 6187-6197. (Pubitemid 37467242)
21. Ramsey KH, Sigar IM, Schripsema JH, Shaba N, Cohoon KP. Expression of matrix metalloproteinases subsequent to urogenital Chlamydia muridarum infection of mice. Infect Immun 2005; 73(10): 6962-6973.
22. Cain TK, Rank RG. Local Th1-like responses are induced by intravaginal infection of mice with the mouse pneumonitis biovar of Chlamydia trachomatis. Infect Immun 1995; 63(5): 1784-1789.
23. Morrison RP, Feilzer K, Tumas DB. Gene knockout mice establish a primary protective role for major histocompatibility complex class IIrestricted responses in Chlamydia trachomatis genital tract infection. Infect Immun 1995; 63(12): 4661-4668.
24. Rank RG, Sanders MM, Patton DL. Increased incidence of oviduct pathology in the guinea pig after repeat vaginal inoculation with the chlamydial agent of guinea pig inclusion conjunctivitis. Sex Transm Dis 1995; 22(1): 48-54.
25. Van Voorhis WC, Barrett LK, Sweeney YT, Kuo CC, Patton DL. Repeated Chlamydia trachomatis infection of Macaca nemestrina fallopian tubes produces a Th1-like cytokine response associated with fibrosis and scarring. Infect Immun 1997; 65(6): 2175-2182.
26. Wolner-Hanssen P, Patton DL, Holmes KK. Protective immunity in pig-tailed macaques after cervical infection with Chlamydia trachomatis. Sex Transm Dis 1991; 18(1): 21-25.
27. Molano M., Meijer CJ, Weiderpass E, et al. The natural course of Chlamydia trachomatis infection in asymptomatic Colombian women: a 5-year follow-up study. J Infect Dis 2005; 191(6): 907-916.
28. Agrawal T, Vats V, Salhan S, Mittal A. Determination of chlamydial load and immune parameters in asymptomatic, symptomatic and infertile women. FEMS Immunol Med Microbiol 2009; 55(2): 250-257.
29. Mittal A, Rastogi S, Reddy BS, Verma S, Salhan S, Gupta E. Enhanced immunocompetent cells in chlamydial cervicitis. J Reprod Med 2004; 49(8): 671-677. (Pubitemid 39128781)
30. Agrawal T, Vats V, Wallace PK, Salhan S, Mittal A. Cervical cytokine responses in women with primary or recurrent chlamydial infection. J Interferon Cytokine Res 2007; 27(3): 221-226. (Pubitemid 46435489)
31. Arno JN, Ricker VA, Batteiger BE, Katz BP, Caine VA, Jones RB. Interferon-gamma in endocervical secretions of women infected with Chlamydia trachomatis. J Infect Dis 1990; 162(6): 1385-1389.
32. Wang C, Tang J, Crowley-Nowick PA, Wilson CM, Kaslow RA, Geisler WM. Interleukin (IL)-2 and IL-12 responses to Chlamydia trachomatis infection in adolescents. Clin Exp Immunol 2005; 142(3): 548-554.
33. Coers J, Starnbach MN, Howard JC. Modeling infectious disease in mice: co-adaptation and the role of host-specific IFN-gamma responses. PLoS Pathog 2009; 5(5): e1000333.
34. Nelson DE, Virok DP, Wood H, et al. Chlamydial IFN-gamma immune evasion is linked to host infection tropism. Proc Natl Acad Sci U S A 2005; 102(30): 10658-10663. (Pubitemid 41061610)
35. Agrawal T, Vats V, Salhan S, Mittal A. Mucosal and peripheral immune responses to chlamydial heat shock proteins in women infected with Chlamydia trachomatis. Clin Exp Immunol 2007; 148(3): 461-468. (Pubitemid 46701021)
36. Ghaem-Maghami S, Ratti G, Ghaem-Maghami M, et al. Mucosal and systemic immune responses to plasmid protein pgp3 in patients with genital and ocular Chlamydia trachomatis infection. Clin Exp Immunol 2003; 132(3): 436-442.
37. Pate MS, Hedges SR, Sibley DA, Russell MW, Hook EW III, Mestecky J. Urethral cytokine and immune responses in Chlamydia trachomatis-infected males. Infect Immun 2001; 69(11): 7178-7181.
38. Beatty WL, Morrison RP, Byrne GI. Persistent chlamydiae: from cell culture to a paradigm for chlamydial pathogenesis. Microbiol Rev 1994; 58(4): 686-699.
39. Hogan RJ, Mathews SA, Mukhopadhyay S, Summersgill JT, Timms P. Chlamydial persistence: beyond the biphasic paradigm. Infect Immun 2004; 72(4): 1843-1855. (Pubitemid 38419894)
40. Debattista J, Timms P, Allan J, Allan J. Immunopathogenesis of Chlamydia trachomatis infections in women. Fertil Steril 2003; 79(6): 1273-1287.
41. Agrawal T, Gupta R, Dutta R, et al. Protective or pathogenic immune response to genital chlamydial infection in women-a possible role of cytokine secretion profile of cervical mucosal cells. Clin Immunol 2009; 130(3): 347-354.
42. Cohen CR, Nguti R, Bukusi EA, et al. Human immunodeficiency virus type 1-infected women exhibit reduced interferon-gamma secretion after Chlamydia trachomatis stimulation of peripheral blood lymphocytes. J Infect Dis 2000; 182(6): 1672-1677.
43. Debattista J, Timms P, Allan J, Allan J. Reduced levels of gammainterferon secretion in response to chlamydial 60 kDa heat shock protein amongst women with pelvic inflammatory disease and a history of repeated Chlamydia trachomatis infections. Immunol Lett 2002; 81(3): 205-210. (Pubitemid 34310226)
44. Medzhitov R. Recognition of microorganisms and activation of the immune response. Nature 2007; 449(7164): 819-826.
45. Brunham RC, Rekart ML. Considerations on Chlamydia trachomatis disease expression. FEMS Immunol Med Microbiol 2009; 55(2): 162-166.
46. Rank RG, Sanders MM. Pathogenesis of endometritis and salpingitis in a guinea pig model of chlamydial genital infection. Am J Pathol 1992; 140(4): 927-936.
47. Robertson JN, Ward ME, Conway D, et al. Chlamydial and gonococcal antibodies in sera of infertile women with tubal obstruction. J Clin Pathol 1987; 40(4): 377-383.
48. Toye B, Laferriere C, Claman P, Jessamine P, Peeling R. Association between antibody to the chlamydial heat-shock protein and tubal infertility. J Infect Dis 1993; 168(5): 1236-1240.
49. World Health Organization Task Force on the Prevention and Management of Infertility. Tubal infertility: serologic relationship to past chlamydial and gonococcal infection. Sex Transm Dis 1995; 22(2): 71-77.
50. Brunham RC, Peeling R, Maclean I, Kosseim ML, Paraskevas M. Chlamydia trachomatis-associated ectopic pregnancy: serologic and histologic correlates. J Infect Dis 1992; 165(6): 1076-1081.
51. Chow JM., Yonekura ML, Richwald GA, Greenland S, Sweet RL, Schachter J. The association between Chlamydia trachomatis and ectopic pregnancy: a matched-pair, case-control study. JAMA 1990; 263 (23): 3164-3167.
52. Bachmann LH, Richey CM, Waites K, Schwebke JR, Hook EW III. Patterns of Chlamydia trachomatis testing and follow-up at a university hospital medical center. Sex Transm Dis 1999; 26(9): 496-499.
53. Geisler WM, Wang C, Morrison SG, Black CM, Bandea CI, Hook EW III. The natural history of untreated Chlamydia trachomatis infection in the interval between screening and returning for treatment. Sex Transm Dis 2008; 35(2): 119-123.
54. Hook EW III, Spitters C, Reichart CA, Neumann TM, Quinn TC. Use of cell culture and a rapid diagnostic assay for Chlamydia trachomatis screening. JAMA 1994; 272(11): 867-870.
55. Morré SA, van den Brule AJ, Rozendaal L, et al. The natural course of asymptomatic Chlamydia trachomatis infections: 45% clearance and no development of clinical PID after one-year follow-up. Int J STD AIDS 2002; 13(Suppl 2): 12-18.
56. Rahm VA, Belsheim J, Gleerup A, Gnarpe H, Rosen G. Asymptomatic carriage of Chlamydia trachomatis-a study of 109 teenage girls. Eur J Sex Transm Dis 1986; 3: 91-94.
57. Ness RB, Soper DE, Holley RL, et al. Effectiveness of inpatient and outpatient treatment strategies for women with pelvic inflammatory disease: results from the PID Evaluation and Clinical Health (PEACH) randomized trial. Am J Obstet Gynecol 2002; 186(5): 929-937.
58. Weström L, Joesoef R, Reynolds G, Hagdu A, Thompson SE. Pelvic inflammatory disease and fertility: a cohort study of 1,844 women with laparoscopically verified disease and 657 control women with normal laparoscopic results. Sex Transm Dis 1992; 19(4): 185-192.
59. Haggerty CL, Ness RB, Amortegui A, et al. Endometritis does not predict reproductive morbidity after pelvic inflammatory disease. Am J Obstet Gynecol 2003; 188(1): 141-148.
60. Hillis SD, Joesoef R, Marchbanks PA, Wasserheit JN, Cates W Jr, Westrom L. Delayed care of pelvic inflammatory disease as a risk factor for impaired fertility. Am J Obstet Gynecol 1993; 168(5): 1503-1509.
61. Wiesenfeld HC, Sweet RL, Ness RB, Krohn MA, Amortegui AJ, Hillier SL. Comparison of acute and subclinical pelvic inflammatory disease. Sex Transm Dis 2005; 32(7): 400-405.
62. Brunham RC, Maclean IW, Binns B, Peeling RW. Chlamydia trachomatis: its role in tubal infertility. J Infect Dis 1985; 152(6): 1275-1282.
63. Patton DL, Moore DE, Spadoni LR, Soules MR, Halbert SA, Wang SP. A comparison of the fallopian tube's response to overt and silent salpingitis. Obstet Gynecol 1989; 73(4): 622-630.
64. Molander P, Sjoberg J, Paavonen J, Cacciatore B. Transvaginal power Doppler findings in laparoscopically proven acute pelvic inflammatory disease. Ultrasound Obstet Gynecol 2001; 17(3): 233-238.
65. Tukeva TA, Aronen HJ, Karjalainen PT, Molander P, Paavonen T, Paavonen J. MR imaging in pelvic inflammatory disease: comparison with laparoscopy and US. Radiology 1999; 210(1): 209-216.
66. Baehr W, Zhang YX, Joseph T, et al. Mapping antigenic domains expressed by Chlamydia trachomatis major outer membrane protein genes. Proc Natl Acad Sci USA 1988; 85(11): 4000-4004.
67. Stephens RS, Sanchez-Pescador R, Wagar EA, Inouye C, Urdea MS. Diversity of Chlamydia trachomatis major outer membrane protein genes. J Bacteriol 1987; 169(9): 3879-3885.
68. Tan C, Spitznagel JK, Shou H-Z, Hsia RC, Bavoil PM. The polymorphic membrane protein gene family of the chlamydiaceae. In: Bavoil PM, Wyrick PB, eds. Chlamydia genomics and pathogenesis. Norfolk, United Kingdom: Horizon Bioscience, 2006: 195-218.
69. Cornelis GR, Van GF. Assembly and function of type III secretory systems. Annu Rev Microbiol 2000; 54: 735-774.
70. Belland RJ, Scidmore MA, Crane DD, et al. Chlamydia trachomatis cytotoxicity associated with complete and partial cytotoxin genes. Proc Natl Acad Sci U S A 2001; 98(24); 13984-13989.
71. Crowley-Nowick PA, Ellenberg JH, Vermund SH, Douglas SD, Holland CA, Moscicki AB. Cytokine profile in genital tract secretions from female adolescents: impact of human immunodeficiency virus, human papillomavirus, and other sexually transmitted pathogens. J Infect Dis 2000; 181(3): 939-945.
72. Wolner-Hanssen P, Eschenbach DA, Paavonen J, et al. Decreased risk of symptomatic chlamydial pelvic inflammatory disease associated with oral contraceptive use. JAMA 1990; 263(1): 54-59.
73. Cohen CR, Sinei SS, Bukusi EA, Bwayo JJ, Holmes KK, Brunham RC. Human leukocyte antigen class II DQ alleles associated with Chlamydia trachomatis tubal infertility. Obstet Gynecol 2000; 95(1): 72-77.
74. Cohen CR, Gichui J, Rukaria R, Sinei SS, Gaur LK, Brunham RC. Immunogenetic correlates for Chlamydia trachomatis-associated tubal infertility. Obstet Gynecol 2003; 101(3): 438-444.
75. Kimani J, Maclean IW, Bwayo JJ, et al. Risk factors for Chlamydia trachomatis pelvic inflammatory disease among sex workers in Nairobi, Kenya. J Infect Dis 1996; 173(6): 1437-1444.
76. Geisler WM, Tang J, Wang C, Wilson CM, Kaslow RA. Epidemiological and genetic correlates of incident Chlamydia trachomatis infection in North American adolescents. J Infect Dis 2004; 190(10): 1723-1729.
77. Wang C, Tang J, Geisler WM, Crowley-Nowick PA, Wilson CM, Kaslow RA. Human leukocyte antigen and cytokine gene variants as predictors of recurrent Chlamydia trachomatis infection in high-risk adolescents. J Infect Dis 2005; 191(7): 1084-1092.
78. Morré SA, Karimi O, Ouburg S. Chlamydia trachomatis: identification of susceptibility markers for ocular and sexually transmitted infection by immunogenetics. FEMS Immunol Med Microbiol 2009; 55(2): 140-153.
79. Chen Y, Timms P, Chen YP. CIDB: Chlamydia Interactive Database for cross-querying genomics, transcriptomics and proteomics data. Biomol Eng 2007; 24(6): 603-608.
80. Wiesenfeld HC, Heine RP, Krohn MA, et al. Association between elevated neutrophil defensin levels and endometritis. J Infect Dis 2002; 186(6): 792-797.
81. Ness RB, Soper DE, Richter HE, et al. Chlamydia antibodies, chlamydia heat shock protein, and adverse sequelae after pelvic inflammatory disease: the PID Evaluation and Clinical Health (PEACH) Study. Sex Transm Dis 2008; 35(2): 129-135.
82. Patton DL, Kuo CC, Wang SP, Halbert SA. Distal tubal obstruction induced by repeated Chlamydia trachomatis salpingeal infections in pig-tailed macaques. J Infect Dis 1987; 155(6): 1292-1299.
83. Rank RG, Bowlin AK, Kelly KA. Characterization of lymphocyte response in the female genital tract during ascending Chlamydial genital infection in the guinea pig model. Infect Immun 2000; 68(9): 5293-5298.
84. Lichtenwalner AB, Patton DL, Van Voorhis WC, Sweeney YT, Kuo CC. Heat shock protein 60 is the major antigen which stimulates delayed-type hypersensitivity reaction in the macaque model of Chlamydia trachomatis salpingitis. Infect Immun 2004; 72(2): 1159-1161.
85. Patton DL, Sweeney YT, Kuo CC. Demonstration of delayed hypersensitivity in Chlamydia trachomatis salpingitis in monkeys: a pathogenic mechanism of tubal damage. J Infect Dis 1994; 169(3): 680-683.
86. Ness RB, Randall H, Richter HE, et al. Condom use and the risk of recurrent pelvic inflammatory disease, chronic pelvic pain, or infertility following an episode of pelvic inflammatory disease. Am J Public Health 2004; 94(8): 1327-1329.
87. Hillis SD, Owens LM, Marchbanks PA, Amsterdam LF, Mac Kenzie WR. Recurrent chlamydial infections increase the risks of hospitalization for ectopic pregnancy and pelvic inflammatory disease. Am J Obstet Gynecol 1997; 176: 103-107.
88. Bakken IJ, Skjeldestad FE, Lydersen S, Nordbo SA. Births and ectopic pregnancies in a large cohort of women tested for Chlamydia trachomatis. Sex Transm Dis 2007; 34(10): 739-743.
89. Low N, Egger M, Sterne JA, et al. Incidence of severe reproductive tract complications associated with diagnosed genital chlamydial infection: the Uppsala Women's Cohort Study. Sex Transm Infect 2006; 82(3): 212-218.
90. Ness RB, Smith KJ, Chang CC, Schisterman EF, Bass DC. Prediction of pelvic inflammatory disease among young, single, sexually active women. Sex Transm Dis 2006; 33(3): 137-142.
91. Hosenfeld CB, Workowski KA, Berman S, et al. Repeat infection with Chlamydia and gonorrhea among females: a systematic review of the literature. Sex Transm Dis 2009; 36(8): 478-489.
92. Brunham RC, Pourbohloul B, Mak S, White R, Rekart ML. The unexpected impact of a Chlamydia trachomatis infection control program on susceptibility to reinfection. J Infect Dis 2005; 192(10): 1836-1844.
93. Brunham RC, Rekart ML. The arrested immunity hypothesis and the epidemiology of chlamydia control. Sex Transm Dis 2008; 35(1): 53-54.
94. Low N. Caution: chlamydia surveillance data ahead. Sex Transm Infect 2008; 84(2): 80-81.
95. Miller WC. Epidemiology of chlamydial infection: are we losing ground? Sex Transm Infect 2008; 84(2): 82-86.
96. Datta SD, Sternberg MR, Satterwhite CL, et al. Trends in Chlamydia trachomatis prevalence in the U.S., 1999-2006: results from the National Health and Nutrition Examination Survey (NHANES). In: Program and abstracts of the 48th Annual ICAAC/IDSA 46th Annual Meeting (Washington, DC). 2008. Abstract L-657.
97. Satterwhite CL, Tian LH, Braxton J, Weinstock H. Chlamydia prevalence among women and men entering the National Job Training Program: United States, 2003-2007. Sex Transm Dis 2010; 37(2): 63-67.
98. Rank RG, Batteiger BE, Soderberg LS. Susceptibility to reinfection after a primary chlamydial genital infection. Infect Immun 1988; 56(9): 2243-2249.
99. Igietseme JU, Rank RG. Susceptibility to reinfection after a primary chlamydial genital infection is associated with a decrease of antigenspecific T cells in the genital tract. Infect Immun 1991; 59(4): 1346-1351.
100. Batteiger BE, Rank RG. Analysis of the humoral immune response to chlamydial genital infection in guinea pigs. Infect Immun 1987; 55(8): 1767-1773.
101. Su H, Morrison R, Messer R, Whitmire W, Hughes S, Caldwell HD. The effect of doxycycline treatment on the development of protective immunity in a murine model of chlamydial genital infection. J Infect Dis 1999; 180(4): 1252-1258.
102. Arno JN, Katz BP, McBride R, et al. Age and clinical immunity to infections with Chlamydia trachomatis. Sex Transm Dis 1994; 21(1): 47-52.
103. Barnes RC, Katz BP, Rolfs RT, Batteiger B, Caine V, Jones RB. Quantitative culture of endocervical Chlamydia trachomatis. J Clin Microbiol 1990; 28(4): 774-780.
104. Quinn TC, Gaydos C, Shepherd M, et al. Epidemiologic and microbiologic correlates of Chlamydia trachomatis infection in sexual partnerships. JAMA 1996; 276(21): 1737-1742.
105. Cohen CR, Koochesfahani KM, Meier AS, et al. Immunoepidemiologic profile of Chlamydia trachomatis infection: importance of heatshock protein 60 and interferon-gamma. J Infect Dis 2005; 192(4): 591-599.
106. Gomes JP, Borrego MJ, Atik B, et al. Correlating Chlamydia trachomatis infectious load with urogenital ecological success and disease pathogenesis. Microbes Infect 2006; 8(1): 16-26.
107. Ficarra M, Ibana JS, Poretta C, et al. A distinct cellular profile is seen in the human endocervix during Chlamydia trachomatis infection. Am J Reprod Immunol 2008; 60(5): 415-425.
108. Lyytikainen E, Kaasila M, Koskela P, et al. Chlamydia trachomatis seroprevalence atlas of Finland 1983-2003. Sex Transm Infect 2008; 84(1): 19-22.
109. Lyytikainen E, Kaasila M, Hiltunen-Back E, et al. A discrepancy of Chlamydia trachomatis incidence and prevalence trends in Finland 1983-2003. BMC Infect Dis 2008; 8: 169.
110. Batteiger BE, Tu W, Ofner S, et al. Repeated Chlamydia trachomatis genital infections in adolescent women. J Infect Dis 2010; 201: 42-51.
111. Ward M, Bailey R, Lesley A, Kajbaf M, Robertson J, Mabey D. Persisting inapparent chlamydial infection in a trachoma endemic community in The Gambia. Scand J Infect Dis Suppl 1990; 69: 137-148.
112. Scholes D, Stergachis A, Heidrich FE, Andrilla H, Holmes KK, Stamm WE. Prevention of pelvic inflammatory disease by screening for cervical chlamydial infection. N Engl J Med 1996; 334(21): 1362-1366. (Pubitemid 26152715)
113. Ostergaard L, Andersen B, Moller JK, Olesen F. Home sampling versus conventional swab sampling for screening of Chlamydia trachomatis in women: a duster-randomized 1-year follow-up study. Clin Infect Dis 2000; 31(4): 951-957.
114. Clark KL, Howell MR, Li Y, et al. Hospitalization rates in female US Army recruits associated with a screening program for Chlamydia trachomatis. Sex Transm Dis 2002; 29(1): 1-5.
115. Oakeshott P, Kerry S, Aghaizu A, et al. Randomised controlled trial of screening for Chlamydia trachomatis to prevent pelvic inflammatory disease: the POPI (prevention of pelvic infection) trial. BMJ 2010; 340: c1642.
116. Sutton MY, Sternberg M, Zaidi A, St Louis ME, Markowitz LE. Trends in pelvic inflammatory disease hospital discharges and ambulatory visits, United States, 1985-2001. Sex Transm Dis 2005; 32(12): 778-784.
117. Bohm MK, Newman L, Satterwhite CL, Tao G, Weinstock HS. Pelvic inflammatory disease among privately insured women, United States, 2001-2005. Sex Transm Dis 2010; 37: 131-136
118. Moss NJ, Ahrens K, Kent CK, Klausner JD. The decline in clinical sequelae of genital Chlamydia trachomatis infection supports current control strategies. J Infect Dis 2006; 193(9): 1336-1338.
119. Paavonen J, Westrom L, Eschenbach DA. Pelvic inflammatory disease. In: Holmes KK, Sparling PF, Stamm WE, Piot P, Wasserheit JN, Corey LA, et al, eds. Sexually transmitted diseases. New York: McGraw Hill Medical, 2008: 1017-1050.
120. Hoover KW, Tao G, Kent CK. Trends in the diagnosis and treatment of ectopic pregnancy among commercially insured women in the United States. Obstet Gynecol 2010; 115(3): 495-502.
121. Centers for Disease Control and Prevention. Chlamydia screening among sexually active young female enrollees of health plans-United States, 2000-2007. MMWR Morb Mortal Wkly Rep 2009; 58(14): 362-365.